Hepatitis B is a serious liver disease caused by the hepatitis B virus (HBV), which is a small DNA virus from the Hepadnaviridae family. If someone has this infection for a long time, it can lead to ...

Five hepatitis viruses vary by transmission and prevention, but HBV and HCV account for the majority of global cirrhosis, hepatocellular carcinoma, and viral hepatitis-related deaths. Vaccination (HAV ...

Vaccination against hepatitis B is a common recommendation, but what exactly is it preventing? HHS Secretary Robert F. Kennedy Jr. and his advisory group plan to meet this week to discuss and vote on ...

The new test enables clinicians to reliably diagnose HDV and monitor patients’ treatment response.Hepatitis D affects nearly ...

In the next 10 years, about 150,000 people in the United States will die from liver cancer and end-stage liver disease associated with chronic hepatitis B and hepatitis C. It is estimated that 3.5–5.3 ...

In the world of viral hepatitis, Hepatitis B (HBV) and Hepatitis C (HCV) are usually at the centre of attention. Although both are viral infections that primarily affect the liver, causing ...

Chronic hepatitis B (CHB) is a long-term infection of the liver caused by the hepatitis B virus (HBV). While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical outcomes of ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, ...

Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and hepatocellular cancer (HCC, liver cancer). It affects approximately 296 million ...